Severe neutropenia is associated with blinatumomab! Blina is not considered myelosuppressive, but have observed severe neutropenia. We studied 95 pts receiving blina in CR at Dana-Farber: 41% gr≥3 neutropenia, 13% ANC <100, no serious infections, not necessarily recurrent! #ALL

Neutropenia with blina may be severe, but complications usually manageable! Important to remember as blina use ↑↑↑ after recent label expansion! Congrats Evan Chen on great project: 10.1080/10428194.2024.2402808

Many thanks Marlise R. Luskin MD, MSCE for your expert mentorship on such a timely topic. Hoping many others will find our work helpful!

A comprehensive, up-to-date and clinically relevant review on NPM1-mutated #AMLsm. Led by Evan_Chen, Marlise R. Luskin MD, MSCE and Richard_Stone, this is trully a clinical pearl for clinicians tinyurl.com/22ws2ftn Dana-Farber News AmericanJournalofHematology